EBAMed
Marina Izzo is the current Chief Executive Officer at Eba, a company focused on non-invasive treatment of cardiac arrhythmias using proton technology. Prior to their current role, Marina held positions such as Chief Executive Officer at CARDIONOVUM and Strategy Consultant at Medyria. With extensive experience in the medical industry, Marina has also worked in various roles at companies like Symetis SA, St. Jude Medical, and Medtronic over the years. Marina holds a Master in Economics from SDA Bocconi and has completed the Director Development Program at The Wharton School.
EBAMed
EBAMed (External Beam Ablation Medical Devices) is developing an Ultrasound Imaging Solution to enable non-invasive treatment of Cardiac Arrhythmias. The device (CardioKit) offers the following functionalities: target position verification before treatment (to aid in patient setup), Cardiac Motion Monitoring during treatment, Respiratory Gating and Cardiac Gating.